Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Liabilities and Shareholders Equity (2021 - 2023)

Historic Liabilities and Shareholders Equity for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $556.4 million.

  • Zymeworks' Liabilities and Shareholders Equity rose 8529.29% to $556.4 million in Q3 2023 from the same period last year, while for Dec 2023 it was $1.8 billion, marking a year-over-year increase of 8537.25%. This contributed to the annual value of $648.7 million for FY2022, which is 6671.08% up from last year.
  • According to the latest figures from Q3 2023, Zymeworks' Liabilities and Shareholders Equity is $556.4 million, which was up 8529.29% from $602.1 million recorded in Q2 2023.
  • Zymeworks' Liabilities and Shareholders Equity's 5-year high stood at $648.7 million during Q4 2022, with a 5-year trough of $300.3 million in Q3 2022.
  • In the last 3 years, Zymeworks' Liabilities and Shareholders Equity had a median value of $578.6 million in 2023 and averaged $516.2 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 6671.08% in 2022, then soared by 8529.29% in 2023.
  • Zymeworks' Liabilities and Shareholders Equity (Quarter) stood at $389.1 million in 2021, then surged by 66.71% to $648.7 million in 2022, then decreased by 14.24% to $556.4 million in 2023.
  • Its Liabilities and Shareholders Equity was $556.4 million in Q3 2023, compared to $602.1 million in Q2 2023 and $600.7 million in Q1 2023.